Skip to content
Assyro AI
FDA Orange Book ยท active-ingredient family

Gentamicin sulfate

Gentamicin sulfate: 3 brands, 57 generics; first approved Feb 18, 1982; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 57 ANDA applications approved.

Brands (NDA)
3
Generics (ANDA)
57
Listed patents
0
Presentations
121

Brand (NDA) products

Originator applications
Ask AI
  • NDA 050505-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 2MG BASE/MLINJECTABLEINTRATHECALDiscontinued-
  • NDA 050039-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • NDA 050425-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASEOINTMENTOPHTHALMICDiscontinued-

Generic (ANDA) products (57)

Abbreviated applications
Ask AI
  • GENTAMICIN SULFATE
    ANDA 2152362024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 2152372024
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONRxAP
  • GENTAMICIN SULFATE
    ANDA 2092332018
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • GENTAMICIN SULFATERS
    ANDA 0650242004
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASEOINTMENTOPHTHALMICRx-
  • GENTAMICIN SULFATE
    ANDA 0651212004
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • ANDA 0641632001
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0640931995
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASEOINTMENTOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0640481994
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICRxAT
  • GENTAMICIN SULFATE
    ANDA 0640561994
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALRxAT
  • GENTAMICIN SULFATE
    ANDA 0640541994
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALRxAT
  • GENTAMICIN SULFATE
    ANDA 0631491991
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0631061991
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0629321988
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 3MG BASE/MLSOLUTION/DROPSOPHTHALMICDiscontinued-
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.6MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 2.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 60MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 70MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 80MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 90MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 120MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0626351987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0626121986
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATERS
    ANDA 06236619862 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONRxAP
    EQ 10MG BASE/MLINJECTABLEINJECTIONRxAP
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 1.2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.6MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 60MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 70MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 80MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 90MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0625231985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • ANDA 0624931985
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 06250719852 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0625341984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • ANDA 0624521984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0625331984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALRxAT
  • ANDA 0625011984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASEOINTMENTOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0625311984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0625301984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 1MG BASE/GMCREAMTOPICALDiscontinued-
  • ANDA 0624801984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0624961984
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0624771983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0624711983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALDiscontinued-
  • ANDA 0624581983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 06242019832 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONRxAP
    EQ 40MG BASE/MLINJECTABLEINJECTIONRxAP
  • Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 1.2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.6MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 60MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 70MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 80MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 90MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 062413198310 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 1.2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.6MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 2MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 60MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 70MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 80MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 90MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0624271983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALDiscontinued-
  • ANDA 0624431983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 3MG BASE/GMOINTMENTOPHTHALMICDiscontinued-
  • ANDA 0624441983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • ANDA 0624401983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0623401983
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 062373198210 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.8MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 80MG BASE/100MLINJECTABLEINJECTIONRx-
    EQ 40MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 60MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONRx-
    EQ 120MG BASE/100MLINJECTABLEINJECTIONRx-
    EQ 1.2MG BASE/MLINJECTABLEINJECTIONRx-
    EQ 1.6MG BASE/MLINJECTABLEINJECTIONRx-
    EQ 2MG BASE/MLINJECTABLEINJECTIONRx-
    EQ 2.4MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 06232519823 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 100MG BASE/100MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 0623541982
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 06235619822 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATERS
    ANDA 0623511982
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALRxAT
  • ANDA 060462-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALDiscontinued-
  • GENTAMICIN SULFATERS
    ANDA 062307-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASECREAMTOPICALRxAT
  • ANDA 062289-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 062288-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 061716-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 1MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 061739-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 062251-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONRxAP
    EQ 10MG BASE/MLINJECTABLEINJECTIONRxAP
  • GENTAMICIN SULFATE
    ANDA 062318-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • GENTAMICIN SULFATE
    ANDA 062264-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 062248-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 10MG BASE/MLINJECTABLEINJECTIONDiscontinued-
    EQ 40MG BASE/MLINJECTABLEINJECTIONDiscontinued-
  • ANDA 060463-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.1% BASEOINTMENTTOPICALDiscontinued-
  • GENTAMICIN SULFATERS
    ANDA 062196-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 0.3% BASESOLUTION/DROPSOPHTHALMICRxAT

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
45 yr 4 mo ago
Most recent approval
2 yr 10 mo ago

Approvals span 1982โ€“2024 across 60 FDA applications.

Brand (NDA) 35%
Generic (ANDA) 5795%

Gentamicin sulfate: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Gentamicin sulfate

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo